Publications

Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.

Verguet, S; Johri, M; Morris, SK; Gauvreau, CL; Jha, P; JIT, M;

2015

Vaccine, (2015).33 10 10.1016/j.vaccine.2014.11.050.

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

GBD 2013 Risk Factors Collaborators,; Forouzanfar, MH; Alexander, L; Anderson, HR; Bachman, VF; Biryukov, S; Brauer, M; Burnett, R; Casey, D; Coates, MM; Cohen, A; Delwiche, K; Estep, K; Frostad, JJ; Astha, KC; Kyu, HH; Moradi-Lakeh, M; Ng, M; Slepak, EL; Thomas, BA; Wagner, J; Aasvang, GM; Abbafati, C; Abbasoglu Ozgoren, A; Abd-Allah, F; ... Murray, CJ.

2015

Lancet, (2015).386 10010 10.1016/S0140-6736(15)00128-2.

Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.

(including White, RG; ),;

2015

Vaccine, (2015).33 26 10.1016/j.vaccine.2015.03.056.

Changing socioeconomic determinants of childhood vaccines: a global analysis over three decades.

DE FIGUEIREDO, A; Johnston, I; SMITH, DM D; LARSON, HJ; Jones, N;

2015

The Lancet Global Health, (2015).3, 10.1016/s2214-109x(15)70139-7.

High-dose influenza vaccines make economic sense for older people.

JIT, M;

2015

The Lancet infectious diseases, (2015).15 12 10.1016/S1473-3099(15)00272-8.

Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial.

PRENTICE, S; WEBB, EL; DOCKRELL, HM; KALEEBU, P; ELLIOTT, AM; COSE, S;

2015

Trials, (2015).16 1 10.1186/s13063-015-0682-5.

Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.

Nyiro, JU; Sande, C; Mutunga, M; Kiyuka, PK; Munywoki, PK; SCOTT, JA G; Nokes, DJ;

2015

Vaccine, (2015).33 15 10.1016/j.vaccine.2015.02.039.

The broader economic impact of vaccination: reviewing and appraising the strength of evidence.

JIT, M; Hutubessy, R; Png, ME; SUNDARAM, N; Audimulam, J; Salim, S; Yoong, J;

2015

BMC medicine, (2015).13 1 10.1186/s12916-015-0446-9.

Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates.

Jones, S; GRIGNARD, L; Nebie, I; Chilongola, J; Dodoo, D; Sauerwein, R; Theisen, M; Roeffen, W; Singh, SK; Singh, RK; Singh, S; Kyei-Baafour, E; TETTEH, K; DRAKELEY, C; BOUSEMA, T;

2015

The Journal of infection, (2015).71 1 10.1016/j.jinf.2015.03.007.

Foot-and-Mouth Disease in Kenya: Epidemiology, disease impact and vaccine effectiveness on large-scale dairy farms.

Lyons, NA;

2015

(2015). 10.17037/PUBS.02172943.